The platform assesses cognitive and motor function via at-home assessments that generate digital biomarkers and a predictive score, supporting the early detection of Parkinson's.

Members, including couples and teens 13 and above, will have access to Talkspace, while members aged 18 and older can receive support with psychiatric medications.

Researchers at Johns Hopkins found that the AI outperformed current clinical guidelines with 89% accuracy across all patients and a 93% accuracy rate for individuals ages 40 to 60.